Dexamethasone for Reduction of Post Thoracotomy Pain Syndrome
Study Details
Study Description
Brief Summary
Post thoracotomy pain syndrome still affects 50% of patients after a thoracic surgery. Pathogenesis is unclear but there is growing evidence that neuro inflammation may play a significant role. Dexamethasone is a very potent anti-inflammatory drug. The hypothesis of this study is that dexamethasone, given pre operatively, would help reduce the incidence of post thoracotomy pain syndrome 3 months after surgery, by reducing the inflammatory response, in patients undergoing elective thoracic surgery that includes thoracic epidural analgesia.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: dexamethasone 10 mg Dexamethasone 10 mg will be given as a single-dose, pre incision, intravenously |
Drug: Dexamethasone
10 mg (2.5 ml)
Other Names:
|
Placebo Comparator: normal saline Patients in this group will receive 2.5 mL of normal saline intravenously, pre-incision |
Drug: Normal Saline
2.5 mL normal saline
Other Names:
|
Outcome Measures
Primary Outcome Measures
- cytokine elevation [24 h after surgery]
Secondary Outcome Measures
- incidence of post thoracotomy pain syndrome [3 months after surgery]
- incidence of post thoracotomy pain syndrome [6 months after surgery]
- incisional and shoulder pain [acute post operative period]
- Brief pain inventory questionnaire [three months after surgery]
- Brief pain inventory questionnaire [6 months after surgery]
- Leeds Assessment of Neuropathic Signs and Symptoms questionnaire [three and six months after surgery]
- cytokine elevation [1h after surgery]
- cytokine elevation [48 h after surgery]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
elective thoracic surgery using a thoracotomy incision and thoracic epidural analgesia
-
ASA I-III
-
age 18-75 yo
Exclusion Criteria:
-
contra-indication to thoracic epidural analgesia
-
patient refusal
-
patients already taking cortisone or dexamethasone
-
patients on chronic opioid medication
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Maisonneuve-Rosemont Hospital | Montreal | Quebec | Canada | H1T 4M5 |
Sponsors and Collaborators
- Maisonneuve-Rosemont Hospital
Investigators
- Principal Investigator: Veronique Brulotte, MD, Msc, Maisonneuve-Rosemont Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- dexaPTPS